Skip to main content
American Journal of Cancer Research logoLink to American Journal of Cancer Research
. 2023 Nov 15;13(11):5750.

A novel selective AKR1C3-activated prodrug AST-3424/OBI-3424 exhibits broad anti-tumor activity

Fanying Meng 1, Wan-Fen Li 2, Donald Jung 1, Chun-Chung Wang 2, Tianyang Qi 1, Chi-Sheng Shia 2, Ren-Yu Hsu 2, Yin-Cheng Hsieh 2, Jianxin Duan 1
PMCID: PMC10695813  PMID: 38058837

In this article, we would like to add the following funding information: This research was funded by the Development and Reform Commission of Shenzhen Municipality, Guangdong Province, P.R.C. (XMHT20220104029).

Therefore, we would like to publish this Erratum to reflect this change. We apologize for this error.


Articles from American Journal of Cancer Research are provided here courtesy of e-Century Publishing Corporation

RESOURCES